Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Metastatic Colorectal Cancer · Metastatic Gastroesophageal Adenocarcinoma · DPD Deficiency
Locations
- CHU Amiens, Amiens, France
- Institut de Cancérologie de l'Ouest, Angers, France
- Institut du Cancer d'Avignon, Avignon, France
- CHU Jean Minjoz, Besançon, France
- Centre Hospitalier de Cholet, Cholet, France
- Centre Georges François Leclerc, Dijon, France
- Hôpital Privé Jean Mermoz, Lyon, France
- Institut Régional du Cancer de Montpellier - ICM Val d'Aurelle, Montpellier, France
- Hôpital Saint Louis, Paris, France
- Hôpital Saint Antoine, Paris, France
- Hôpital Cochin, Paris, France
- Hôpital des Diaconesses Croix Saint Simon, Paris, France
- Hospices Civils de Lyon, Pierre-Bénite, France
- CHU de Poitiers, Poitiers, France
- CHU de REIMS, Reims, France
- Institut Godinot, Reims, France
- Institut de Cancérologie de l'Ouest - Site René Gauducheau, Saint-Herblain, France
- CHU Saint-Etienne, Saint-Priest-en-Jarez, France
- CH de Saint-Malo, St-Malo, France
- Hôpital Nord Franche-Comté / Site du Mittan, Trévenans, France
- Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France